COMMON STOCK PURCHASE WARRANT Issue Date: December 16, 2015 To Purchase 50,000 Shares of Common Stock of VIVEVE MEDICAL, INC.Securities Agreement • December 21st, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Jim Atkinson (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the earlier of the tenth anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viveve Medical, Inc., a Yukon Territory corporation (the “Company”), up to an aggregate of 50,000 shares (the “Warrant Shares”) of the Company’s common stock, no par value (the “Common Stock”) in accordance with Section 3 or Section 4 herein. The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.70 subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
LOCK-UP AGREEMENTLock-Up Agreement • June 23rd, 2016 • Atkinson James G. • Electromedical & electrotherapeutic apparatus • New York
Re: Underwriting Agreement, dated June 14, 2016, by and between Viveve Medical, Inc. and Ladenburg Thalmann & Co. Inc., acting as representative to the several underwriters
Agreement of Joint FilingJoint Filing Agreement • December 3rd, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingJoint Filing Agreement • December 21st, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingJoint Filing Agreement • June 23rd, 2016 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingJoint Filing Agreement • May 22nd, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Viveve Medical, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
COMMON STOCK PURCHASE WARRANT Issue Date: May 12, 2015 To Purchase 217,733 Shares of Common Stock of VIVEVE MEDICAL, INC.Securities Agreement • December 3rd, 2015 • Atkinson James G. • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, James Atkinson (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the earlier of the tenth anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viveve Medical, Inc., a Yukon Territory corporation (the “Company”), up to an aggregate of 217,733 shares (the “Warrant Shares”) of the Company’s common stock, no par value (the “Common Stock”) in accordance with Section 3 or Section 4 herein. The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.53, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
